NOVEL ALLANTOINNACETYLSALYCILIC ACIDDALUMINUM MOLECULAR COMPOUND AND M ETHOD OF MAKING SAMEPURPOSE:A molecular compound of allantoin-acetylsalicylic acid-aluminum of the formula (m is 3-6, n is 1-3); for example, 1-allantoin/5-acetylsalicylic acid/aluminum.SHINNO KYOSHI...
Performing the experiment of mutating a fixed core of acetylsalicylic acid to increase itsQEDvalue. fromevomolimportrun_modelmodel_path="examples/3_detailed_tree"run_model({"obj_function":"qed","optimization_parameters": {"max_steps":10,"pop_max_size":10,"k_to_replace":2,"mutable_init_po...
©2008ElsevierB.V.Allrightsreserved.1.IntroductionThemixtureoftheactiveingredients,acetylsalicylicacid(ASA),caffeineandparacetamolisawidelyusedpharmaceuticalcombi-nationwithanalgesiceffects.Themostcommonanalyticalmethodsusedforthedeterminationofthesecompoundsincludehighper-formanceliquidchromatographyandextractionfollowedbyUV...
Dubayle D, Malissin I, Menétrey D: Differential effects of two analgesic drugs, morphine chlorhydrate and acetylsalicylic acid, on thalamic mast cell numbers in rat. J Neuroimmunol 2005, 169: 106–115. 10.1016/j.jneuroim.2005.08.008 Article CAS PubMed Google Scholar Robbins MS, Lipton RB...
NOVEL ALLANTOINNACETYLSALYCILIC ACIDDALUMINUM MOLECULAR COMPOUND AND M ETHOD OF MAKING SAMEPURPOSE:A molecular compound of allantoin-acetylsalicylic acid-aluminum of the formula (m is 3-6, n is 1-3); for example, 1-allantoin/5-acetylsalicylic acid/aluminum.SHINNO KIYOSHI...
inflammatory disorders; with the proviso that when A is absent, n is 0, and B is absent, then R1-CO- is different from the acyl residue of acetylsalicylic acid; and non-toxic pharmaceutically acceptable acid addition salts thereof; and non-toxic pharmaceutically acceptable cation salts thereof....
(i) a group of the formula: R1 - CO - (11) wherein R1-CO- represents the acyl residue of a carboxylic acid drug (R1-COOH) used in the treatment of inflammatory disorders; or (ii) a group of the formula: R2 - O - (12) wherein R2-O- refers to the C-21 alkoxide residue of...
(i) a group of the formula: R1 - CO - (11) wherein R1-CO- represents the acyl residue of a carboxylic acid drug (R1-COOH) used in the treatment of inflammatory disorders; or (ii) a group of the formula: R2 - O - (12) wherein R2-O- refers to the C-21 alkoxide residue of...
(R2-OH) or any other anti-inflammatory drug containing a hydroxy functional group; with the proviso that when A is absent, n is 0, and B is absent, then R1-CO- is different from the acyl residue of acetylsalicylic acid; and non-toxic pharmaceutically acceptable acid addition or cation ...